Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 PatientsFrancesca Minoia, Angelo Ravelli, Sergio Davì et al.|Arthritis & Rheumatology|2014Cited by 430
Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritisFrancesca Minoia, Angelo Ravelli, Francesca Bovis et al.|Annals of the Rheumatic Diseases|2019Cited by 109
Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritisJessica Tibaldi, Nicolino Ruperto, Raju Khubchandani et al.|Lara D. Veeken|2020Cited by 66
Increased incidence of inflammatory bowel disease on etanercept in juvenile idiopathic arthritis regardless of concomitant methotrexate useJoeri W. van Straalen, Joost F. Swart, Roline M. Krol et al.|Lara D. Veeken|2021Cited by 26